http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019086292-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39923b1ebc6a6b2537fa257ab6186205
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cffb6a03ab87db5882d0fc331044c6c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0188c7f4203c234bce17afe0e0bac43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_600c3325cf6f84134431d08fb41a219d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca91cbafc1ad51446d80cccdc29da6e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71131fdef8bc7d767faadc93a08e40bd
publicationDate 2019-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019086292-A1
titleOfInvention Process for the preparation of the crystalline form iii of tipiracil hydrochloride
abstract PROCESS FOR THE PREPARATION OF THE CRYSTALLINE FORM III OF TIPIRACIL HYDROCHLORIDE The present invention concerns a process for the preparation of the crystalline form III of Tipiracil hydrochloride having a content of residual solvents lower than the ICH limits. Said process is advantageous with respect to the known processes because it allows the production of the form III of Tipiracil hydrochloride suitable for use in the preparation of pharmaceutical finished products.
priorityDate 2017-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9630346-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3012255-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9903778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450238591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6256

Total number of triples: 31.